165 related articles for article (PubMed ID: 36896195)
1.
Koyama M; Yamaguchi K; Chigusa Y; Yamanoi K; Taki M; Sunada M; Horie A; Hamanishi J; Minamiguchi S; Mandai M
Int Cancer Conf J; 2023 Apr; 12(2):120-125. PubMed ID: 36896195
[TBL] [Abstract][Full Text] [Related]
2. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
[TBL] [Abstract][Full Text] [Related]
3. Uterine Adenosarcoma.
Ulrich UA; Denschlag D
Oncol Res Treat; 2018; 41(11):693-696. PubMed ID: 30326467
[TBL] [Abstract][Full Text] [Related]
4. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
Momeni Boroujeni A; Kertowidjojo E; Wu X; Soslow RA; Chiang S; Da Silva EM; Weigelt B; Chui MH
Mod Pathol; 2022 Nov; 35(11):1684-1694. PubMed ID: 36138078
[TBL] [Abstract][Full Text] [Related]
5. Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth.
Seidman JD; Wasserman CS; Aye LM; MacKoul PJ; O'Leary TJ
Am J Surg Pathol; 1999 Jul; 23(7):809-14. PubMed ID: 10403304
[TBL] [Abstract][Full Text] [Related]
6. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
Gallardo A; Prat J
Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
[TBL] [Abstract][Full Text] [Related]
7. Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis.
Ngo C; Cotteret S; Deneche I; Kfoury M; Chehab R; Tran-Dien A; Vibert J; Leary A; Gouy S; Maulard A; Morice P; Scoazec JY; Pautier P; Genestie C
Hum Pathol; 2024 Apr; 148():14-22. PubMed ID: 38688412
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian adenosarcoma with elevated CA125 antigen. Case report and literature review].
Recinos-Money E; Escobar-Alfaro G; Contreras J; Zepeda-Castilla E; Parra-Torres C; Di Castro P
Cir Cir; 2008; 76(1):71-5. PubMed ID: 18492424
[TBL] [Abstract][Full Text] [Related]
9. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
[TBL] [Abstract][Full Text] [Related]
10. Uterine Adenosarcoma: a Review.
Nathenson MJ; Ravi V; Fleming N; Wang WL; Conley A
Curr Oncol Rep; 2016 Nov; 18(11):68. PubMed ID: 27718181
[TBL] [Abstract][Full Text] [Related]
11. [Uterin adenosarcoma: French Guidelines of the French Sarcoma Group and the Rare Gynecologic Tumor Group].
Karabajakian A; Genestie C; Meeus P; Guyon F; Llacer Moscardo C; Croce S; Taieb S; Duffaud F; Pautier P; Ray-Coquard I; Blay JY
Bull Cancer; 2023; 110(7-8):836-843. PubMed ID: 37202293
[TBL] [Abstract][Full Text] [Related]
12. Uterine Adenosarcoma with Sarcomatous Overgrowth and Rhabdoid Features: A Rare Case.
Rashid S; Akhtar M
Saudi J Med Med Sci; 2022; 10(1):72-76. PubMed ID: 35283707
[TBL] [Abstract][Full Text] [Related]
13. Adenosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 11 cases.
Blom R; Guerrieri C
Int J Gynecol Cancer; 1999 Jan; 9(1):37-43. PubMed ID: 11240741
[TBL] [Abstract][Full Text] [Related]
14. Mullerian adenosarcomas of the uterine cervix with sarcomatous overgrowth.
Kudela E; Nachajova M; Balharek T; Gabonova E; Danko J
Curr Probl Cancer; 2019 Aug; 43(4):371-376. PubMed ID: 30522776
[TBL] [Abstract][Full Text] [Related]
15. Uterine müllerian adenosarcoma with sarcomatous overgrowth and lung metastasis in a 25-year-old woman.
Choi YJ; Jung MH; Park YK; Lee BY; Huh CY
Eur J Gynaecol Oncol; 2011; 32(1):91-4. PubMed ID: 21446335
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite Instability Status and the Expression of p16 and Cyclin D1 Proteins in Uterine Adenosarcoma and Their Clinicopathological Significance.
Atilgan AO; Akcay EY; Ozen O; Haberal Reyhan AN; Ayhan A
Turk Patoloji Derg; 2023; 39(1):31-41. PubMed ID: 35876683
[TBL] [Abstract][Full Text] [Related]
17. Uterine Adenosarcoma with Sarcomatous Overgrowth: A Case Report of Aggressive Disease in a 16-Year-Old Girl and a Literature Review.
Liu H; Shen Z; Wu D; Zhou Y
J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):426-431. PubMed ID: 29317258
[TBL] [Abstract][Full Text] [Related]
18. Primary vaginal adenosarcoma with sarcomatous overgrowth.
Toyoshima M; Akahira J; Moriya T; Hayakawa S; Yaegashi N
Gynecol Oncol; 2004 Dec; 95(3):759-61. PubMed ID: 15582000
[TBL] [Abstract][Full Text] [Related]
19. The Overexpression of Programmed Death-Ligand 2 in Uterine Adenosarcoma: Correlation with High-Grade Morphology, Mutant Type TP53 Expression and Clinical Outcomes.
Ok Atılgan A; Yılmaz Akçay E; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):352-364. PubMed ID: 35466759
[TBL] [Abstract][Full Text] [Related]
20. Müllerian adenosarcoma of the uterine cervix with sarcomatous overgrowth: A case report of aggressive disease in a young patient.
Morales F DA; Medina R ML; Trujillo LM; Beltrán MI; Dulcey IC
Int J Surg Case Rep; 2016; 27():155-161. PubMed ID: 27621097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
